Opaleye Management Inc. - Jun 15, 2021 Form 4/A - Amendment Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Stock symbol
ETON
Transactions as of
Jun 15, 2021
Transactions value $
-$847,350
Form type
4/A - Amendment
Date filed
6/21/2021, 06:05 AM
Date Of Original Report
Jun 17, 2021
Previous filing
Jun 17, 2021
Next filing
Jun 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETON Common Stock, par value $0.001 per share Sale -$815K -101K -2.77% $8.07 3.55M Jun 15, 2021 By Opaleye, L.P. F1
transaction ETON Common Stock, par value $0.001 per share Sale -$32.3K -4K -2.75% $8.07 142K Jun 15, 2021 By Managed Account F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Managed Account.